Tempus AI announced a collaboration with the Institute for Follicular Lymphoma Innovation. The goal of the collaboration is to advance targeted therapy development for follicular lymphoma by ...
Hosted on MSN1mon
Tempus AI: A Game-Changer in AI-Powered HealthcareGame-Changing Launch: "Olivia" Health App The more significant driver of Tempus' rally was the announcement of its new AI-enabled health app, Olivia. Designed as a personal health concierge ...
CHICAGO, February 18, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a new collaboration with the Institute for Follicular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback